9 Jun 2017 11:45
Â
 | ||||
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES | ||||
 |  | |||
1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii | CONVATEC GROUP PLC | |||
2 Reason for the notification (please tick the appropriate box or boxes): | ||||
An acquisition or disposal of voting rights | ü | |||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | Â | |||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | Â | |||
An event changing the breakdown of voting rights | Â | |||
Other (please specify): | Â | Â | ||
3. Full name of person(s) subject to thenotification obligation: iii | NORDIC CAPITAL VI LIMITED NORDIC CAPITAL VII LIMITED Â | |||
4. Full name of shareholder(s)Â (if different from 3.):iv | CIDRON HEALTHCARE TOPCO LIMITED CIDRON HEALTHCARE CO-INVEST LIMITED CIDRON HEALTHCARE CO-INVEST II LIMITED | |||
5. Date of the transaction and date onwhich the threshold is crossed orreached: v | Â 8 JUNE 2017 | |||
6. Date on which issuer notified: | 9 JUNE 2017 | |||
7. Threshold(s) that is/are crossed orreached: vi, vii | Below 8% | |||
 |  |  |  |  |
Â
8. Notified details: | ||||||||||||||||
A: Voting rights attached to shares viii, ix | ||||||||||||||||
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction | ||||||||||||||
NumberofShares | NumberofVotingRights | Numberof shares | Number of votingrights | % of voting rights x | ||||||||||||
Direct | Direct xi | Indirect xii | Direct | Indirect | ||||||||||||
ORDINARY SHARES OF £0.10 EACH | 314,158,828 | 314,158,828 | 143,158,828 | N/A | 143,158,828 | N/A | 7.34% | |||||||||
GB00BD3VFW73 | ||||||||||||||||
 | ||||||||||||||||
B: Qualifying Financial Instruments | ||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||
Type of financialinstrument | Expirationdate xiii | Exercise/Conversion Period xiv | Number of votingrights that may beacquired if theinstrument isexercised/ converted. | % of votingrights | ||||||||||||
N/A | Â | Â | Â | Â | ||||||||||||
 | ||||||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | ||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||
Type of financialinstrument | Exercise price | Expiration date xvii | Exercise/Conversion period xviii | Number of voting rights instrument refers to  | % of voting rights xix, xx  | |||||||||||
N/A | Â | Â | Â | Â Â | Nominal | Delta | ||||||||||
 |  | |||||||||||||||
 | ||||||||||||||||
Total (A+B+C) | ||||||||||||||||
Number of voting rights | Percentage of voting rights | |||||||||||||||
 143,158,828  | 7.34% | |||||||||||||||
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Â
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi | ||
Nordic Capital VI Limited is the General Partner of Nordic Capital VI Alpha, L.P. and Nordic Capital VI Beta, L.P. (Fund VI) and is responsible for managing Fund VI. Â Nordic Capital VII Limited is the General Partner of Nordic Capital VII Alpha, L.P. and Nordic Capital VII Beta, L.P. (Fund VII) and is responsible for managing Fund VII. Â Fund VI and Fund VII hold shares in Cidron Healthcare Topco Limited (Topco). Topco in turn holds one management share in each of Cidron Healthcare Co-invest Limited and Cidron Healthcare Co-invest II Limited. | ||
 | ||
Proxy Voting: | ||
10. Name of the proxy holder: | N/A | |
11. Number of voting rights proxy holder will ceaseto hold: | N/A | |
12. Date on which proxy holder will cease to holdvoting rights: | N/A | |
 | ||
13. Additional information: | This disclosure has been calculated based on an issued share capital of 1,951,472,651 shares as disclosed by ConvaTec Group Plc in its AGM results announcement dated 11 May 2017. | |
14. Contact name: | LYNDA ELLIOTT | |
15. Contact telephone number: | + 44 1534 605105 | |
 |  |  |
Â
Â